Leukaemia stem cells and the evolution of cancer-stem-cell research

Nature Reviews Cancer

Volumn 5, Issue 4, 2005, Pages 311-321

  Huntly, Brian J P ^a   Gilliland, D Gary ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; CD123 ANTIGEN; CD19 ANTIGEN; CD20 ANTIGEN; CD34 ANTIGEN; CD38 ANTIGEN; CD45 ANTIGEN; CD45RA ANTIGEN; CD71 ANTIGEN; CELL SURFACE MARKER; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; HLA DR ANTIGEN; HOX PROTEIN; INTERLEUKIN 3 RECEPTOR; MIXED LINEAGE LEUKEMIA PROTEIN; NOTCH RECEPTOR; SYNDECAN 1; THY 1 ANTIGEN; TRANSCRIPTION FACTOR RUNX1; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; CANCER RESEARCH; CELL RENEWAL; CLONOGENESIS; CONTROLLED STUDY; GENE MUTATION; GENE REARRANGEMENT; HEMATOPOIETIC STEM CELL; HISTORY OF MEDICINE; IMMUNOPHENOTYPING; LEUKEMIA CELL; MOUSE; NATURAL KILLER CELL; NEPHROBLASTOMA; NEURAL STEM CELL; NONHUMAN; ONTOGENY; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; PROTEIN FAMILY; REVIEW; SCID MOUSE; SIGNAL TRANSDUCTION; STEM CELL; TERATOCARCINOMA; X CHROMOSOME INACTIVATION;

ANIMALS; CELL DIVISION; DRUG DELIVERY SYSTEMS; HEMATOPOIETIC STEM CELLS; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HUMANS; LEUKEMIA; MICE; MODELS, BIOLOGICAL; RESEARCH; TRANSCRIPTION, GENETIC; TUMOR MARKERS, BIOLOGICAL; TUMOR STEM CELLS;

EID: 16844378799     PISSN: 1474175X     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrc1592     Document Type: Review

References (126)

1. Main, J. M. & Prehn, R. T. Successful skin homografts after the administration of high dosage X radiation and homologous bone marrow. J. Natl Cancer Inst. 15, 1023-1029 (1955).
2. Till, J. E. & McCulloch, E. A. A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. Radiat. Res. 14, 213-222 (1961).
3. Pappenheim, A. Prinzipen der neuren morphologischen haematozytologie nach zytogenetischer grundlage. Folia Haematol. 21, 91-101 (1917).
4. Reynolds, B. A. & Weiss, S. Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science 255, 1707-1710 (1992).
5. Blanpain, C., Lowry, W. E., Geoghegan, A., Polak, L. & Fuchs, E. Self-renewal, multipotency, and the existence of two cell populations within an epithelial stem cell niche. Cell 118, 635-648 (2004).
6. Smith, G. H. & Medina, D. A morphologically distinct candidate for an epithelial stem cell in mouse mammary gland. J. Cell Sci. 90 (Part 1), 173-183 (1988).
7. Kordon, E. C. & Smith, G. H. An entire functional mammary gland may comprise the progeny from a single cell. Development 125, 1921-1930 (1998).
8. Park, C. H., Bergsagel, D. E. & McCulloch, E. A. Mouse myeloma tumor stem cells: a primary cell culture assay. J. Natl Cancer Inst. 46, 411-422 (1971).
9. Bruce, W. R. & Van Der Gaag, H. A quantitative assay for the number of murine lymphoma cells capable of proliferation in vivo. Nature 199, 79-80 (1963).
10. Sabbath, K. D., Ball, E. D., Larcom, P., Davis, R. B. & Griffin, J. D. Heterogeneity of clonogenic cells in acute myeloblastic leukemia. J. Clin. Invest. 75, 746-753 (1985).
11. Griffin, J. & Lowenberg, B. Clonogenic cells in acute myeloblastic leukemia. Blood 68, 1185-1195 (1986).
12. Hamburger, A. W. & Salmon, S. E. Primary bioassay of human tumor stem cells. Science 197, 461-463 (1977).
13. Southam, C. & Brunschwig, A. Quantitative studies of autotransplantation of human cancer. Cancer 14, 461-463 (1961).
14. Virchow, R. Editorial. Virchows Arch. Pathol. Anat. Physiol. Klin. Med. 3, 23 (1855).
15. Cohnheim, J. Ueber entzundung und eiterung. Path. Anat. Physiol. Klin. Med. 40, 1-79 (1867).
16. Beckwith, J. B., Kiviat, N. B. & Bonadio, J. F. Nephrogenic rests, nephroblastomatosis, and the pathogenesis of Wilms' tumor. Pediatr. Pathol. 10, 1-36 (1990).
17. Wiemels, J. L. et al. Prenatal origin of acute lymphoblastic leukaemia in children. Lancet 354, 1499-1503 (1999).
18. Gale, K. B. et al. Backtracking leukemia to birth: identification of clonotypic gene fusion sequences in neonatal blood spots. Proc. Natl Acad. Sci. USA 94, 13950-13954 (1997).
19. Wiemels, J. L. et al. In utero origin of t(8;21) AML1-ETO translations in childhood acute myeloid leukemia. Blood 99, 3801-3805 (2002).
20. Greaves, M. F. & Wiemels, J. Origins of chromosome translocations in childhood leukaemia. Nature Rev. Cancer 3, 639-649 (2003).
21. Pierce, G. B. & Johnson, L. D. Differentiation and cancer. In Vitro 7, 140-145 (1971).
22. Potter, V. R. Phenotypic diversity in experimental hepatomas: the concept of partially blocked ontogeny. The 10th Walter Hubert Lecture. Br. J. Cancer 38, 1-23 (1978).
23. Sell, S. & Pierce, G. B. Maturation arrest of stem cell differentiation is a common pathway for the cellular origin of teratocarcinomas and epithelial cancers. Lab. Invest 70, 6-22 (1994).
24. Reya, T., Morrison, S., Clarke, M. & Weissman, I. Stem cells, cancer, and cancer stem cells. Nature 414, 105-111 (2001).
25. Kondo, M. et al. Biology of hematopoietic stem cells and progenitors: implications for clinical application. Annu. Rev. Immunol. 21, 759-806 (2003).
26. Ibrahim, S. F. & van den Engh, G. High-speed cell sorting fundamentals and recent advances. Curr. Opin Biotechnol. 14, 5-12 (2003).
27. Herzenberg, L. A., Parks, D., Sahaf, B., Perez, O. & Roederer, M. The history and future of the fluorescence activated cell sorter and flow cytometry: a view from Stanford. Clin. Chem. 48, 1819-1827 (2002).
28. Fialkow, P., Gartler, S. M. & Yoshida, A. Clonal origin of chronic myelocytic leukemia in man. Proc. Natl Acad. Sci. USA 58, 1468-1471 (1967).
29. Fialkow, P. et al. Acute nonlymphocytic leukemia: heterogeneity of stem cell origin. Blood 57, 1068-1073 (1981).
30. Fialkow, J. P., Faguet, G. B., Jacobson, R. J., Vaidya, K. & Murphy, S. Evidence that essential thrombocythemia is a clonal disorder with origin in a multipotent stem cell. Blood 58, 916-919(1981).
31. Fialkow, P. J., Jacobson, R. J. & Papayannopoulou, T. Chronic myelocytic leukemia: clonal origin in a stem cell common to the granulocyte, erythrocyte, platelet and monocyte/macrophage. Am. J. Med. 63, 125-130 (1977).
32. Bonnet, D. & Dick, J. E. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nature Med 3, 730-737 (1997).
33. McCune, J. M. et al. The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function. Science 241, 1632-1639 (1988).
34. Kamel-Reid, S. et al. A model of human acute lymphoblastic leukemia in immune-deficient SCID mice. Science 246, 1597-1600 (1989).
35. Sirard, C. et al. Normal and leukemic SCID-repopulating cells (SRC) coexist in the bone marrow and peripheral blood from CML patients in chronic phase, whereas leukemic SRC are detected in blast crisis. Blood 87, 1539-1548 (1996).
36. Lapidot, T. et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 367, 645-648 (1994).
37. Jordan, C. T. et al. The interleukin-3 receptor α chain is a unique marker for human acute myelogenous leukemia stem cells. Leukemia 14, 1777-1784 (2000).
38. Blair, A., Hogge, D. E., Ailles, L. E., Lansdorp, P. M. & Sutherland, H. J. Lack of expression of Thy-1 (CD90) on acute myeloid leukemia cells with long-term proliferative ability in vitro and in vivo. Blood 89, 3104-3112 (1997).
39. -. Blood 92, 4325-4335 (1998).
40. Blair, A. & Sutherland, H. J. Primitive acute myeloid leukemia cells with long-term proliferative ability in vitro and in vivo lack surface expression of c-kit (CD117). Exp. Hematol. 28, 660-671 (2000).
41. Cobaleda, C. et al. A primitive hematopoietic cell is the target for the leukemic transformation in human Philadelphia-positive acute lymphoblastic leukemia. Blood 95, 1007-1013 (2000).
42. Cox, C. V. et al. Characterization of acute lymphoblastic leukemia progenitor cells. Blood 104, 2919-2925 (2004).
43. Deininger, M., Goldman, J. & Melo, J. The molecular biology of chronic myeloid leukemia. Blood 96, 3343-3356 (2000).
44. Martin, P. J. et al. Involvement of the B-lymphoid system in chronic myelogenous leukaemia. Nature 287, 49-50 (1980).
45. Jamieson, C. H. et al. Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML. N. Engl. J. Med. 351, 657-667 (2004).
46. Al-Hajj, M., Wicha, M., Benito-Hernandez, A., Morrison, S. & Clarke, M. Prospective identification of tumorigenic breast cancer cells. Proc. Natl Acad. Sci. USA 100, 3983-3988, (2003).
47. Singh, S. K. et al. Identification of a cancer stem cell in human brain tumors. Cancer Res. 63, 5821-5828 (2003).
48. Hemmati, H. D. et al. Cancerous stem cells can arise from pediatric brain tumors. Proc. Natl Acad. Sci. USA 100, 15178-15183 (2003).
49. Ignatova, T. N. et al. Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro. Glia 39, 193-206 (2002).
50. Singh, S. K. et al. Identification of human brain tumour initiating cells. Nature 432, 396-401 (2004).
51. Chesier, S., Morrison, S., Liao, X. & Weissman, I. In vivo proliferation and cell cycle kinetics of long-term self-renewing hematopoietic stem cells. Proc. Natl Acad. Sci. USA 96, 3120-3125 (1999).
52. Bradford, G., Williams, B., Rossi, R. & Bertoncello, I. Quiescence, cycling, and turnover in the primitive hematopoietic stem cell compartment. Exp. Hematol. 25, 445-453 (1997).
53. Lansdorp, P. Self-renewal of stem cells. Biol. Blood Marrow Transplant. 3, 171-178 (1997).
54. Morrison, S., Prowse, K., Ho, P. & Weissman, I. Telomerase activity in hematopoietic cells is associated with self-renewal potential. Immunity 5, 207-216 (1996).
55. Manz, M. G., Miyamoto, T., Akashi, K. & Weissman, I. L. Prospective isolation of human clonogenic common myeloid progenitors. Proc. Natl Acad. Sci. USA 99, 11872-11877 (2002).
56. -) in acute myeloid leukemia. Stood 86, 1139-1117 (1995).
57. + subpopulations. Stood 86, 2906-2912. (1995).
58. - marrow compartment in children with acute lymphoblastic leukemia. Leukemia 11, 1508-1515 (1997).
59. Passegue, E., Wagner, E. F. & Weissman, I. L. JunB deficiency leads to a myetoproliferative disorder arising from hematopoietic stem cells. Cell 119, 431-443 (2004).
60. Hope, K. J., Jin, L. & Dick, J. E. Acute myeloid leukemia originates from a hierarchy of leukemic stem cell classes that differ in self-renewal capacity. Nature Immunol. 5, 738-743 (2004).
61. Cozzio, A. et al. Similar MLL-associated leukemias arising from self-renewing stem cells and short-lived myeloid progenitors. Genes Dev. 17, 3029-3035 (2003).
62. Huntly, B. J. P. et al. MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors. Cancer Cell 6, 587-596 (2004).
63. Ernst, P., Wang, J. & Korsmeyer, S. J. The role of MLL in hematopoiesis and leukemia. Curr. Opin. Hematol. 9, 282-287 (2002).
64. Deguchi, K. et al. MOZ-TIF2-induced acute myeloid leukemia requires the MOZ nucleosome binding motif and TIF2-mediated recruitment of CBP. Cancer Cell 3, 259-271 (2003).
65. Huntly, B. J. & Gilliland, D. G. Blasts from the past: new lessons in stem cell biology from chronic myelogenous leukemia. Cancer Cell 6, 199-201 (2004).
66. Park, I. K. et al. Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells. Nature 423, 302-305 (2003).
67. Lessard, J. & Sauvageau, G. Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells. Nature 423, 255-260 (2003).
68. Ohta, H. et al. Polycomb group gene rae28 is required for sustaining activity of hematopoietic stem cells. J. Exp. Med. 195, 759-770 (2002).
69. Reya, T. et al. A role for Wnt signalling in self-renewal of haematopoietic stem cells. Nature 423, 409-414 (2003).
70. Muller-Tidow, C. et al. Translocation products in acute myeloid leukemia activate the Wnt signalling pathway in hematopoietic cells. Mol. Cell Biol. 24, 2890-2903 (2004).
71. Zheng, X. et al. γ-catenin contributes to leukemogenesis induced by AML-associated translocation products by increasing the self-renewal of very primitive progenitor cells. Blood 103, 3535-3543 (2004).
72. Varnum-Finney, B. et al. Pluripotent, cytokine-dependent, hematopoietic stem celis are immortalized by constitutive Notch1 signaling. Nature Med 6, 1278-1281 (2000).
73. Karanu, F. N. et al. The notch ligand jagged-1 represents a novel growth factor of human hematopoietic stem cells. J. Exp. Med. 192, 1365-1372 (2000).
74. Zhang, Y. & Kalderon, D. Hedgehog acts as a somatic stem cell factor in the Drosophila ovary. Nature 410, 599-604 (2001).
75. Wechsler-Reya, R. J. & Scott, M. P. Control of neuronal precursor proliferation in the cerebellum by Sonic Hedgehog. Neuron 22, 103-114 (1999).
76. Sauvageau, G. et al. Overexpression of HOXB4 in hematopoietic cells causes the selective expansion of more primitive populations in vitro and in vivo. Genes Dev. 9, 1753-1765 (1995).
77. Thorsteinsdottir, U., Sauvageau, G. & Humphries, R. K. Enhanced in vivo regenerative potential of HOXB4-transduced hematopoietic stem cells with regulation of their pool size. Blood 94, 2605-2612 (1999).
78. Antonchuk, J., Sauvageau, G. & Humphries, R. K. HOXB4-induced expansion of adult hematopoietic stem cells ex vivo. Cell 109, 39-55 (2002).
79. Pardal, R., Clarke, M. F. & Morrison, S. J. Applying the principles of stem-cell biology to cancer. Nature Rev. Cancer 3, 895-902 (2003).
80. Valk-Lingbeek, M. E., Bruggeman, S. W. & van Lohuizen, M. Stem cells and cancer: the polycomb connection. Cell 118, 409-418 (2004).
81. Taipale, J. & Beachy, P. A. The Hedgehog and Wnt signalling pathways in cancer. Nature 411, 349-354 (2001).
82. Sohweisguth, F. Notch signaling activity. Curr. Biol. 14, R129-R138 (2004).
83. Shen, O. et al. Endothelial cells stimulate self-renewal and expand neurogenesis of neural stem cells. Science 304, 1338-1340 (2004).
84. Hitoshi, S. et al. Notch pathway molecules are essential for the maintenance, but not the generation, of mammalian neural stem cells. Genes Dev. 16, 846-858 (2002).
85. Radtke, F., Wilson, A., Mancini, S. J. & MacDonald, H. R. Notch regulation of lymphocyte development and function. Nature Immunol. 5, 247-253 (2004).
86. Weng, A. P. & Aster, J. C. Multiple niches for Notch in cancer: context is everything. Curr. Opin. Genet. Dev. 14, 48-54 (2004).
87. Radtke, F. & Raj, K. The role of Notch in tumorigenesis: oncogene or tumour suppressor? Nature Rev. Cancer 3, 756-767 (2003).
88. Ellisen, L. W. et al. TAN-1, the human homolog of the Drosophila Notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms. Cell 66, 649-661 (1991).
89. Aster, J. C. et al. Essential roles for ankyrin repeat and transactivation domains in induction of T-cell leukemia by Notch1. Mol. Cell. Biol. 20, 7505-7515 (2000).
90. Hoemann, C. D., Beaulieu, N., Girard, L., Rebai, N. & Jolicoeur, P. Two distinct Notch1 mutant alleles are involved in the induction of T-cell leukemia in c-myc transgenic mice. Mol. Cell. Biol. 20, 3831-3842 (2000).
91. Weng, A. P. et al. Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science 306, 269-271 (2004).
92. Berry, L. W., Westlund, B. & Schedl, T Germ-line tumor formation caused by activation of glp-1, a Caenorhabditis elegans member of the Notch family of receptors. Development 124, 925-936 (1997).
93. Krumlauf, R. Hox genes in vertebrate development. Cell 78, 191-201 (1994).
94. Pineault, N., Helgason, C. D., Lawrence, H. J. & Humphries, R. K. Differential expression of Hox, Meis1, and Pbx1 genes in primitive cells throughout murine hematopoietic ontogeny. Exp. Hematol. 30, 49-57 (2002).
95. Lawrence, H. J. et al. Mice bearing a targeted interruption of the homeobox gene HQXA9 have defects in myeloid, erythroid, and lymphoid hematopoiesis. Blood 89, 1922-1930 (1997).
96. Kappen, C. Disruption of the homeobox gene Hoxb-6 in mice results in increased numbers of early erythrocyte progenitors. Am. J. Hematol. 65, 111-115, (2000).
97. Thorsteinsdottir, U. et al. Overexpression of the myeloid leukemia-associated Hoxa9 gene in bone marrow cells induces stem cell expansion. Blood 99, 121-129 (2002).
98. Krosl, J., Beslu, N., Mayotte, N., Humphries, R. K. & Sauvageau, G. The competitive nature of HOXB4-transduced HSC is limited by PBX1: the generation of ultra-competitive stem cells retaining full differentiation potential. Immunity 18, 561-571 (2003).
99. Look, A. Oncogenic transcription factors in the human acute leukaemias. Science 278, 1059-1064 (1997).
100. Borrow, J. et al. The t(7;11)(p15;p15) translocation in acute myeloid leukaemia fuses the genes for nucleoporin NUP98 and class I homeoprotein HOXA9. Nature Genet. 12, 159-167 (1996).
101. Raza-Egilmez, S. Z. et al. NUP98-HOXD13 gene fusion in therapy-related acute myelogenous leukemia. Cancer Res. 58, 4269-4273 (1998).
102. Hatano, M., Roberts, C. W., Minden, M., Christ, W. M. & Korsmeyer, S. J. Deregulation of a homeobox gene, HOX11, by the t(10;14) in T cell leukemia. Science 253, 79-82 (1991).
103. Ferrando, A. A. et al. Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. Cancer Cell 1, 75-87 (2002).
104. Golub, T R. et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 286, 531-537 (1999).
105. Sauvageau, G. et al. Overexpression of HOXB3 in hematopoietic cells causes defective lymphoid development and progressive myeloproliferation. Immunity 6, 13-22 (1997).
106. Perkins, A., Kongsuwan, K., Visvader, J., Adams, J. M. & Cory, S. Homeobox gene expression plus autocrine growth factor production elicits myeloid leukemia. Proc. Natl Acad. Sci. USA 87, 8398-8402 (1990).
107. Thorsteinsdottir, U. et al. Overexpression of HOXA10 in murine hematopoietic cells perturbs both myeloid and lymphoid differentiation and leads to acute myeloid leukemia. Mol. Cell. Biol. 17, 495-505 (1997).
108. Yu, B. D., Hess, J. L., Horning, S. E., Brown, G. A. & Korsmeyer, S. J. Altered Hox expression and segmental identity in Mll-mutant mice. Nature 378, 505-508 (1995).
109. Ayton, P. M. & Cleary, M. L. Molecular mechanisms of leukemogenesis mediated by MLL fusion proteins. Oncogene 20, 5695-5707 (2001).
110. Daser, A. & Rabbitts, T. H. Extending the repertoire of the mixed-lineage leukemia gene MLL in leukemogenesis. Genes Dev. 18, 965-74 (2004).
111. Armstrong, S. A., Golub, T. R. & Korsmeyer, S. J. MLL-rearranged leukemias: insights from gene expression profiling. Semin. Hematol. 40, 268-273 (2003).
112. Davidson, A. J. et al. cdx4 mutants fail to specify blood progenitors and can be rescued by multiple hox genes. Nature 425, 300-306 (2003).
113. Mlodzik, M. & Gehring, W. J. Expression of the caudal gene in the germ line of Drosophila: formation of an RNA and protein gradient during early embryogenesis. Cell 48, 465-478 (1987).
114. Chase, A. et al. Fusion of ETV6 to the caudal-related homeobox gene CDX2 in acute myeloid leukemia with the t(12;13)(p13;q12). Blood 93, 1025-1031 (1999).
115. Rawat, V. P. et al. Ectopic expression of the homeobox gene Cdx2 is the transforming event in a mouse model of t(12;13)(p13;q12) acute myeloid leukemia. Proc. Natl Acad. Sci. USA 101, 817-822 (2004).
116. Ayton, P. & Cleary, M. Molecular mechanisms of leukemogenesis mediated by MLL fusion proteins. Oncogene 20, 5695-5707 (2001).
117. Kelly, L. & Gilliland, D. Genetics of myeloid leukemias. Annu. Rev. Genomics Hum. Genet. 3, 179-198 (2002).
118. Hanahan, D. & Weinberg, R. The hallmarks of cancer. Cell 100, 57-70 (2000).
119. Guzman, M. L. et al. Preferential induction of apoptosis for primary human leukemia stem cells. Proc. Natl Acad. Sci. USA 99, 16220-16225 (2002).
120. Guzman, M. et al. The sesquiterpene lactone parthenolide induces apoptosis of human acute leukemia stem and progenitor cells. Blood 1 Feb 2005 (doi: 10.1182/blood-2004-10-4135).
121. Bonner, W. A., Hulett, H. R., Sweet, R. G. & Herzenberg, L. A. Fluorescence activated cell sorting. Rev. Sci. Instrum. 43, 404-409 (1972).
122. Czitrom, A. A. et al. The function of antigen-presenting cells in mice with severe combined immunodeficiency. J. Immunol. 134, 2276-2280 (1985).
123. Prochazka, M., Gaskins, H. R., Shultz, L. D. & Leiter, E. H. The nonobese diabetic seid mouse: model for spontaneous thymomagenesis associated with immunodeficiency. Proc. Natl Acad. Sci. USA 89, 3290-3294 (1992).
124. Dick, J. E. Human stem cell assays in immune-deficient mice. Curr. Opin. Hematol. 3, 405-409 (1996).
125. Larochelle, A. et al. Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: implications for gene therapy. Nature Med. 2, 1329-1337 (1996).
126. Wang, J. C. et al. High level engraftment of NOD/SCID mice by primitive normal and leukemic hematopoietic cells from patients with chronic myeloid leukemia in chronic phase. Blood 91, 2406-2414 (1998).